DIMENSIONAL FUND ADVISORS LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 201 filers reported holding PTC THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$644,660
-13.1%
15,851
+3.5%
0.00%
Q1 2023$741,907
+128927.3%
15,316
+1.7%
0.00%
Q4 2022$575
-99.9%
15,061
-3.4%
0.00%
Q3 2022$783,000
-71.1%
15,593
-75.7%
0.00%
-100.0%
Q2 2021$2,714,000
-14.2%
64,228
-3.9%
0.00%0.0%
Q1 2021$3,163,000
-33.0%
66,809
-13.7%
0.00%
-50.0%
Q4 2020$4,724,000
+25.9%
77,394
-3.6%
0.00%0.0%
Q3 2020$3,753,000
-3.1%
80,256
+5.1%
0.00%0.0%
Q2 2020$3,873,000
-2.7%
76,333
-14.5%
0.00%0.0%
Q1 2020$3,979,000
+140.1%
89,303
+158.7%
0.00%
+100.0%
Q4 2019$1,657,000
-47.0%
34,525
-62.7%
0.00%0.0%
Q3 2019$3,129,000
-61.4%
92,512
-48.7%
0.00%
-66.7%
Q2 2019$8,114,000
+1.2%
180,309
-15.3%
0.00%0.0%
Q1 2019$8,015,000
-4.2%
212,926
-12.7%
0.00%
-25.0%
Q4 2018$8,369,000
-17.1%
243,852
+13.5%
0.00%0.0%
Q3 2018$10,100,000
+39.3%
214,8830.0%0.00%
+33.3%
Q2 2018$7,248,000
+22.5%
214,883
-1.7%
0.00%
+50.0%
Q1 2018$5,916,000
-32.0%
218,613
-58.1%
0.00%
-50.0%
Q4 2017$8,697,000
-17.2%
521,392
-0.7%
0.00%
-20.0%
Q3 2017$10,507,000
+8.4%
525,110
-0.7%
0.01%
+25.0%
Q2 2017$9,689,000
+88.4%
528,586
+1.1%
0.00%
+100.0%
Q1 2017$5,143,000
+50.9%
522,626
+67.3%
0.00%0.0%
Q4 2016$3,409,000
-22.4%
312,460
-0.3%
0.00%0.0%
Q3 2016$4,391,000
+521.1%
313,418
+211.0%
0.00%
Q2 2016$707,000100,7830.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders